690416 August 2014 Rev . 1
PAML
QUANTA Lite ®
Calprotectin
Differentiate between IBS and IBD with a non-invasive marker of intestinal inflammation . 1
Now available , an FDA cleared assay that delivers the results physicians need for patients with symptoms of IBD
• A new fecal ELISA test kit offering expanded dynamic range of 15.6-500mg / kg 1
• High sensitivity helps guide decision-making when selecting patients for endoscopy 2
For more information visit www . inovadx . com
Scan this QR code or go to www . inovadx . com / calprotectin to learn more about this important marker
INOVA Diagnostics , Inc ., San Diego , CA 92131 858-586-9900 www . inovadx . com
References : 1 . QUANTA Lite Calprotectin directional insert . 2 . Bunn , S . et al . Fecal calprotectin : validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease . J Pediatric Gastroenterology Nutrition 2001 ; 33:14-22 .
QUANTA Lite is a trademark of Inova Diagnostics , Inc . © 2015 Inova Diagnostics , Inc . All rights reserved .